Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Alpha-1 Antitrypsin Augmentation Therapy: Phase III started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Talecris began the open-label, international Phase III STAMP trial in 35 patients. ......

Alpha-1 Antitrypsin Augmentation Therapy: Phase III started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home